title: Audit of suspected chronic intestinal pseudo-obstruction in patients with gynecologic cancer.
abstract: OBJECTIVE
  To describe chronic intestinal pseudo-obstruction (IPO) syndromes that occur after radiotherapy or chemotherapy (or both) for gynecologic cancer.
  
  
  METHODS
  All 48 patients in the study population had a history of gynecologic cancer, treatment with radiotherapy or chemotherapy (or both), and suspected chronic IPO. The final diagnosis was based on clinical symptoms, radiographic imaging, motility studies, and surgical findings. Treatment was expectant for 27 patients and surgical for 21.
  
  
  RESULTS
  In six of the 21 surgical patients, the final diagnosis was mechanical obstruction. In the other 15, it was IPO syndrome: six had an idiopathic dysfunction (ID) and nine had a thick fibrinous coating (FC) on the serosal surface. Intestines of these 15 patients had patent lumens but decreased motility. The ID and FC groups differed in mean age, chemotherapy administration, and mean time from radiotherapy to surgery. Symptoms improved in 67% of FC patients compared with 17% of ID patients. Among patients treated expectantly, symptoms improved in 50% of the ID patients and in 38% of the FC patients. Motility studies were useful for distinguishing ID from FC or mechanical obstruction.
  
  
  CONCLUSIONS
  Clinical history and motility studies may assist in diagnosing IPO syndrome in gynecologic cancer patients treated with radiotherapy or chemotherapy (or both) and in identifying patients who might benefit from surgical intervention.
authors.affiliation: Department of Obstetrics and Gynecology, Mayo Clinic, Rochester MN 55905, USA. mariani.andrea@mayo.edu
authors.forename: A
authors.initials: A
authors.lastname: Mariani
authors.forename: M
authors.initials: M
authors.lastname: Camilleri
authors.forename: I A
authors.initials: IA
authors.lastname: Petersen
authors.forename: E M
authors.initials: EM
authors.lastname: Ward
authors.forename: G
authors.initials: G
authors.lastname: Farrugia
authors.forename: D G
authors.initials: DG
authors.lastname: Kelly
authors.forename: K C
authors.initials: KC
authors.lastname: Podratz
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D015331:Cohort Studies; D005260:Female; D005769:Gastrointestinal Motility; D005833:Genital Neoplasms, Female / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D007418:Intestinal Pseudo-Obstruction / Q000175:diagnosis / Q000209:etiology* / Q000601:surgery; D008875:Middle Aged; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects